[Federal Register Volume 88, Number 83 (Monday, May 1, 2023)]
[Notices]
[Pages 26547-26548]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-09063]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Healthcare Infection Control Practices Advisory Committee

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with regulatory provisions, the Centers for 
Disease Control and Prevention (CDC) announces the following meeting 
for the Healthcare Infection Control Practices Advisory Committee 
(HICPAC). This virtual meeting is open to the public, limited only by 
room seating available (120). The public is also welcomed to listen to 
the meeting via Zoom; 500 teleconference lines are available. Time will 
be available for public comment. Registration is required.

DATES: The meeting will be held on June 8, 2023, 9 a.m. to 5 p.m., EDT, 
and June 9, 2023, 9 a.m. to 12 p.m., EDT.

ADDRESSES: Registration is required to attend in person or on the 
phone. Interested parties must be processed in accordance with 
established federal policies and procedures and may

[[Page 26548]]

register at https://www.cdc.gov/hicpac. All registered participants 
will receive instructions shortly before the meeting. Please click 
first link for day one and the second link for day two to join the 
webinar:
    https://cdc.zoomgov.com/j/1616828862?pwd=N3hmSTEvQjQ3ZHFScVMyM1k2Mk8yUT09.
    Meeting ID: 161 682 8862.
    Passcode: 74249065.
    https://cdc.zoomgov.com/j/1614944394?pwd=UWdBRDNNK2pDdS9PMjlMZzYvRVFzZz09.
    Meeting ID: 161 494 4394.
    Passcode: 26658671.

FOR FURTHER INFORMATION CONTACT: Sydnee Byrd, M.P.A., HICPAC, National 
Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Centers 
for Disease Control and Prevention, l600 Clifton Road NE, Mailstop H16-
3, Atlanta, Georgia 30329. Telephone (404) 718-8039; Email: 
[email protected].

SUPPLEMENTARY INFORMATION: 
    Purpose: The Committee is charged with providing advice and 
guidance to the Director, Division of Healthcare Quality Promotion, the 
Director, NCEZID, the Director, CDC, and the Secretary, Health and 
Human Services, regarding (1) the practice of healthcare infection 
prevention and control; (2) strategies for surveillance, prevention, 
and control of infections, antimicrobial resistance, and related events 
in settings where healthcare is provided; and (3) periodic updating of 
CDC guidelines and other policy statements regarding prevention of 
healthcare-associated infections and healthcare-related conditions.
    Matters To Be Considered: The agenda will include updates on CDC's 
activities for prevention of healthcare-associated infections. It will 
also include updates from the following HICPAC workgroups: the 
Isolation Precautions Guideline workgroup, the Dental Unit Waterline 
Guideline Workgroup, the Healthcare Personnel Guideline Workgroup, the 
Neonatal Intensive Care Unit Guideline Workgroup, and the National 
Healthcare Safety Network Workgroup. The agenda also includes updates 
on CDC and DHQP activities. Agenda items are subject to change as 
priorities dictate.

Public Participation

    Oral Public Comment: Time will be available for public comment. 
Members of the public who wish to provide public comments should plan 
to attend the public comment session at the start time listed. Please 
note that the public comment period may end before the time indicated, 
following the last call for comments.
    Written Public Comment: The public is welcomed to submit written 
comments in advance of the meeting. Comments should be submitted in 
writing by email to the contact person listed above. The deadline for 
receipt of written public comment is May 26, 2023. All requests must 
contain the name, address, and organizational affiliation of the 
speaker, as well as the topic being addressed. Written comments should 
not exceed one single-spaced typed page in length and delivered in 3 
minutes or less. Written comments received in advance of the meeting 
will be included in the official record of the meeting.
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-09063 Filed 4-28-23; 8:45 am]
BILLING CODE 4163-19-P